Impaired fibrinolysis and early atherosclerosis in impaired glucose tolerance and newly detected type 2 diabetes

Fibrinolysis and Proteolysis

Volumn 13, Issue SUPPL. 1, 1999, Pages 11-15

  Temelkova Kurktschiev, T ^a,b   Siegert, G ^a   Koehler, C ^a   Henkel, E ^a   Hanefeld, M ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR; PROINSULIN; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; BODY MASS; CHOLESTEROL BLOOD LEVEL; COMMON CAROTID ARTERY; CONFERENCE PAPER; ENZYME IMMUNOASSAY; FIBRINOLYSIS; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; ULTRASOUND;

EID: 0033067364     PISSN: 13690191     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Lowe LP, Liu K, Greenland P, Metzger BE, Dyer AR, Stamler J. Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men. Diab Care 1997; 20: 163-169
2. Hanefeld M, Fischer S, Julius U et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 1996; 39: 1577-1583
3. Hanefeld M, Temelkova-Kurktschiev T. The postprandial state and the risk of atherosclerosis. Diabet Med 1997; 14: S6-S12
4. Jarrett RJ. The cardiovascular risk associated with impaired glucose tolerance. Diabet Med 1996; 13: SIS519
5. Panahloo A, Yudkin JS. Diminished flbrinolysis in diabetes mellitus and its implication for diabetic vascular disease. Coron Artery Dis 1996; 7: 723-731
6. Nordt TK, Peter K, Kubier W, Bode C. Regulation of the synthesis of plasminogen activator inhibitor type 1 (PAI1): pathogenetic mechanism of atherosclerosis in diabetes mellitus9 Fibrinolysis & Proteolysis 1997; 11 (Suppl 2): 141-147
7. Heiss G, Sharett AR, Barnes R, Chambless LE, Szklo M, Alzola C, for the ARIC Investigators. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol 1991; 134: 250-256
8. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 1991; 11: 1245-1249
9. Temelkova-Kurktschiev T, Koehler C, Schaper F, Henkel E, Hahnefeld A, Fuecker K, Siegert G, Hanefeld M. Relationship between fasting plasma glucose, atherosclerosis risk factors and carotid intima media thickness in nondiabetic individuals. Diabetologia 1998; 41: 706-712
10. The Expert Committee on the Diagnosis and Classification of Diabetes mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes mellitus. Diabetes Care 1997; 20: 1183-1197
11. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimai plus medial thickness of the arterial wall: A direct measurement with ultrasound imaging. Circulation 1986; 74: 1399-1406
12. Fujii S. PAI-1 in thrombosis and arteriosclerosis. Fibrinolysis and Proteolysis 1997; 11(2): 137-140
13. Juhan-Vague I, Roul C, Alessi MC et al. Increased plasminogen activator inhibitor activity in non-insulindependent diabetes subjects. Relationship with plasma insulin. Thromb Haemost 1989; 61: 370-373
14. Ceriello A. Acute hyperglycemia and oxidative stress generation. Diabet Med 1997; 14: 545-49
15. Maiello M, Boeri D, Podesta F et al. Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in elevated glucose. Diabetes 1992:41: 1009-1015
16. Juhan-Vague I, Alessi MC. PAI-1, obesity, insulin resistance and risk of cardiovascular events. Thromb Haemost 1997; 78: 656-660
17. Nagi DK, Tracy R, Pratley R. Relationship of hepatic and peripheral insulin resistance with plasminogen activator inhibitor-1 in Pima Indians. Metabolism 1996; 45: 1243-1247
18. IS.Alessi MC, Juhan-Vague I, Kooista T, Declerck PJ, Collen D. Insulin stimulates the synthesis of plasminogen activator inhibitor-! by the human hepatocellular cell line Hep G2. Thromb Haemost 1988; 60: 491-494
19. Stiko-Rahm A, Wiman B, Hamsten A, Nilsson J. Secretion of plasminogen activator inhibitor 1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein. Arteriosclerosis 1990; 10: 1067-1073
20. Salomaa V, Stinson V, Kark JD, Folsom AR, Davis CE, Wu KK. Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation 1995; 91: 284-290